Subtopic Deep Dive
Host Immune Response to Tuberculosis
Research Guide
What is Host Immune Response to Tuberculosis?
Host immune response to tuberculosis encompasses innate and adaptive immune mechanisms against Mycobacterium tuberculosis (Mtb), including granuloma formation, cytokine production, T-cell activation, and bacterial evasion strategies.
Research examines interferon-gamma (IFN-γ) production by T cells for macrophage activation (Flynn et al., 1993, 2449 citations). Granulomas contain infection but enable latency (Flynn and Chan, 2001, 2124 citations). Tumor necrosis factor (TNF-α) neutralization increases disseminated TB risk (Keane et al., 2001, 3673 citations). Over 10 key papers span 1991-2008.
Why It Matters
IFN-γ knockout mice show disseminated TB, proving its essential role and guiding cytokine-based therapies (Flynn et al., 1993; Cooper et al., 1993). Infliximab, a TNF-α inhibitor, triggers active TB reactivation, mandating latent TB screening before anti-TNF therapy in millions of patients (Keane et al., 2001). These insights drive host-directed therapies to boost vaccine efficacy like BCG recombinants and shorten treatment durations (Stover et al., 1991). Understanding evasion informs latency-targeting drugs.
Key Research Challenges
Cytokine Balance Disruption
Excess TNF-α inhibition causes rapid TB dissemination (Keane et al., 2001). IFN-γ is protective but insufficient alone against latency (Flynn et al., 1993). Balancing pro- and anti-inflammatory cytokines remains unresolved (Flynn and Chan, 2001).
Granuloma Dynamics Modeling
Granulomas contain Mtb but permit persistence (Flynn and Chan, 2001). T-cell recruitment fails in IFN-γ deficient models (Cooper et al., 1993). Dynamic imaging and modeling of granuloma evolution lag behind.
Immune Evasion Mechanisms
Mtb adapts transcriptionally in macrophages, evading killing (Schnappinger et al., 2003). Persistence via glyoxylate shunt resists nutrient starvation (McKinney et al., 2000). Targeting these pathways therapeutically challenges specificity.
Essential Papers
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · 2001 · New England Journal of Medicine · 3.7K citations
Active tuberculosis may develop soon after the initiation of treatment with infliximab. Before prescribing the drug, physicians should screen patients for latent tuberculosis infection or disease.
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
JoAnne L. Flynn, John Chan, K J Triebold et al. · 1993 · The Journal of Experimental Medicine · 2.4K citations
Tuberculosis, a major health problem in developing countries, has reemerged in recent years in many industrialized countries. The increased susceptibility of immunocompromised individuals to tuberc...
Immunology of Tuberculosis
JoAnne L. Flynn, John Chan · 2001 · Annual Review of Immunology · 2.1K citations
The resurgence of tuberculosis worldwide has intensified research efforts directed at examining the host defense and pathogenic mechanisms operative in Mycobacterium tuberculosis infection. This re...
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Andrea M. Cooper, Dyana K. Dalton, Timothy A. Stewart et al. · 1993 · The Journal of Experimental Medicine · 2.0K citations
The expression of protective immunity to Mycobacterium tuberculosis in mice is mediated by T lymphocytes that secrete cytokines. These molecules then mediate a variety of roles, including the activ...
CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database
Brian Alcock, William Huynh, Romeo Chalil et al. · 2022 · Nucleic Acids Research · 1.7K citations
Abstract The Comprehensive Antibiotic Resistance Database (CARD; card.mcmaster.ca) combines the Antibiotic Resistance Ontology (ARO) with curated AMR gene (ARG) sequences and resistance-conferring ...
New use of BCG for recombinant vaccines
C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · 1991 · Nature · 1.5K citations
Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies
Christie Y. Jeon, Megan Murray · 2008 · PLoS Medicine · 1.5K citations
DM was associated with an increased risk of TB regardless of study design and population. People with DM may be important targets for interventions such as active case finding and treatment of late...
Reading Guide
Foundational Papers
Start with Flynn et al. (1993) for IFN-γ proof in resistance; Flynn and Chan (2001) reviews full immunology; Keane et al. (2001) for clinical TNF risks.
Recent Advances
Jeon and Murray (2008) links diabetes to TB susceptibility; Schnappinger et al. (2003) on Mtb macrophage transcription.
Core Methods
Mouse gene disruption (Cooper et al., 1993); gene expression profiling (Schnappinger et al., 2003); nutrient starvation models (Betts et al., 2002).
How PapersFlow Helps You Research Host Immune Response to Tuberculosis
Discover & Search
Research Agent uses citationGraph on Flynn et al. (1993) to map 2449-cited IFN-γ networks, revealing Cooper et al. (1993) connections. exaSearch queries 'granuloma T-cell evasion Mtb' for 50+ latent TB papers. findSimilarPapers expands Keane et al. (2001) to TNF-α therapy risks.
Analyze & Verify
Analysis Agent runs readPaperContent on Flynn and Chan (2001) to extract cytokine profiles, then verifyResponse with CoVe against Keane et al. (2001) for TNF-IFN interactions. runPythonAnalysis processes citation data with pandas for IFN-γ paper trends; GRADE grades evidence as A-level for mouse models (Flynn et al., 1993).
Synthesize & Write
Synthesis Agent detects gaps in granuloma persistence therapies via contradiction flagging between Flynn et al. (1993) protection and McKinney et al. (2000) evasion. Writing Agent uses latexEditText for cytokine diagrams, latexSyncCitations for 10-paper reviews, and latexCompile for grant proposals. exportMermaid visualizes IFN-γ → macrophage → granuloma pathways.
Use Cases
"Analyze cytokine data from IFN-γ knockout TB studies"
Research Agent → searchPapers 'IFN-γ tuberculosis mice' → Analysis Agent → runPythonAnalysis (pandas plots of dissemination rates from Flynn et al. 1993, Cooper et al. 1993) → matplotlib graphs of survival curves.
"Draft review on TNF-α inhibition and TB risk"
Research Agent → citationGraph Keane et al. 2001 → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (10 papers) + latexCompile → PDF with granuloma figure.
"Find code for Mtb macrophage gene expression models"
Research Agent → paperExtractUrls Schnappinger et al. 2003 → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable R scripts for transcriptional adaptation profiles.
Automated Workflows
Deep Research workflow scans 50+ papers on 'host immunity Mtb', chaining searchPapers → citationGraph → structured report with GRADE-scored cytokine roles (Flynn et al., 1993). DeepScan applies 7-step CoVe to verify granuloma claims across Keane et al. (2001) and Flynn and Chan (2001). Theorizer generates hypotheses on combined IFN-γ/TNF therapies from evasion papers (McKinney et al., 2000).
Frequently Asked Questions
What defines host immune response to TB?
Innate immunity via macrophages and adaptive T-cell IFN-γ production form granulomas to contain Mtb (Flynn and Chan, 2001).
What are key methods in this research?
Mouse knockouts demonstrate IFN-γ essentiality (Flynn et al., 1993); transcriptional profiling reveals Mtb macrophage adaptation (Schnappinger et al., 2003).
What are foundational papers?
Flynn et al. (1993, 2449 citations) proves IFN-γ role; Keane et al. (2001, 3673 citations) links TNF inhibition to TB risk.
What open problems exist?
Therapeutic targeting of granuloma persistence and Mtb evasion like glyoxylate shunt without immune disruption (McKinney et al., 2000).
Research Tuberculosis Research and Epidemiology with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Host Immune Response to Tuberculosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers